Comorbosità mediche

10 dic 2019 - Comorbosità mediche

Systematic Review for the 2018

The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol found little evidence to support  ...

10 dic 2019 - Comorbosità mediche

The ODYSSEY Outcomes trial: Clinical implications and exploration of the limits of what can be achie

Proprotein convertase subtilisin/kexin type 9 inhibitors reduce risk for major adverse cardiac events. There is debate about efficacy in patients wit ...

Copyright ┬ę 2021 | SICS S.r.l. - Via Boncompagni 16 - 00187 Roma | Partita IVA: 07639150965
Con il contributo educazionale DIETOSYSTEM